Skip to main content
. 2012 Mar 22;18(1):75–83. doi: 10.3350/kjhep.2012.18.1.75

Table 2.

Genotypic resistance profiles at the on-treatment and off-treatment time points

graphic file with name kjhep-18-75-i002.jpg

*The number of all patients were 25, but the blood samples of the off-treatment time point in four patients were not available.

ND, not detectable; ADV, adefovir dipivoxil; ETV, entecavir; LAM, lamivudine.